Compare studies and check their requirements with the research team.
This study is completed in the United States. It is testing Iloperidone Long-acting Injection (LAI) for schizophrenia.
In United StatesThis study is completed in the United States. It is testing mazdutide Compared With Placebo for Addiction.
In United StatesThis study is completed in the United States. It is testing multiple Oral Doses of Luvadaxistat for schizophrenia.
In United States
This study is enrolling by invitation in the United States. It is testing primary Care Treatment for Eating disorders.
In United StatesThis study is completed in the United States, in Bulgaria, in Czechia, .... It is testing RL-007 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Safety and Efficacy of SAGE-547 for depression.
In United StatesThis study was terminated in the United States, in Bulgaria, in Hungary, .... It is testing CVL-231 (Emraclidine) for schizophrenia.
In United StatesThis study is completed in the United States. It is testing SAGE-217 for depression.
In United StatesThis study is completed in the United States. It is testing SAGE-547 for depression.
In United States
This study is completed in the United States. It is testing Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) for depression.
In United StatesThis study is completed in the United States. It is testing Abuse Potential of EB-1020 Immediate-Release for ADHD.
In United StatesThis study is completed in the United States. It focuses on Addiction.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.